Back to search

Article

Lipid lowering alone fails to limit atherosclerosis progression and neutrophilic inflammation in middle-aged mice

2025-11-05

Abstract excerpt

While cholesterol lowering remains the cornerstone therapy for atherosclerosis and prevention of major adverse cardiovascular events, 33–50% of individuals on lipid-lowering therapy continue to exhibit elevated inflammation. Middle age (MA) represents a critical window for disease acceleration, underscoring a need to better understand non-resolving inflammation in this time frame. We rendered young (2 months) and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bed28a74-b44d-5c6d-863c-77a2ce54fba3
DOI
10.1101/2025.11.04.686598
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lipid lowering alone fails to limit atherosclerosis progression and neutrophilic inflammation in middle-aged miceDOI 10.1101/2025.11.04.686598
Select a neighboring publication to make it the new centre.